CHI Health Saint Francis Saint Francis Alc and Drug Trt Center

CHI Health Saint Francis Saint Francis Alc and Drug Trt Center is an addiction-treatment facility located in Grand Island, NE. The facility offers a continuum of care across multiple levels — Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at CHI Health Saint Francis Saint Francis Alc and Drug Trt Center

The facility offers a continuum of care across multiple levels — Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

CHI Health Saint Francis Saint Francis Alc and Drug Trt Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. What tends to produce post-admission financial surprise is not the facility being out of network — it is the verbal assurance that did not make it into writing. Ask for the written VOB before admission, save the email, and the rest of the financial conversation becomes a lot simpler.

Before you call

Before admission to CHI Health Saint Francis Saint Francis Alc and Drug Trt Center, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.